Remarkably, the CD64+ cDC2 displayed higher levels of the DC activation marker CD40 shown as median fluorescent intensity (MFI), compared with CD64− cDC2 and cDC1, when analyzed across all three different tumor stages. This evidence concerns the gene MPPE1 and neoplasm.